Aurobindo Pharma launches HIV treatment tablet for children
Aurobindo Pharma Ltd has introduced an innovative HIV triple combination tablet specially designed for children living with HIV in low- […]
Say something
Aurobindo Pharma Ltd has introduced an innovative HIV triple combination tablet specially designed for children living with HIV in low- […]
Mumbai-headquartered drug firm, Ajanta Pharma has launched blood pressure lowering tablet in the US market. The medicine has been launched […]
Global pharmaceutical company Strides Shasun Limited has announced that it has received approval from the United States Food and Drug […]
Nevro Corp. has announced that it has received approval from the United States Food and Drug Administration (FDA) for its […]
Medtronic, Inc. has announced it has received United States Food and Drug Administration (FDA) approval, under a humanitarian device exemption […]
Indian drug firm Strides Arcolab has received USFDA approval for the generic Fluorouracil Injection which will be used to treat […]
Indian made vaccine for meningitis has saved 250 million lives in Africa by the efforts of World Health Organization (WHO) and PATH, an NGO.
Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Aravind Eye Hospital’s Aurolab which produces Intra Ocular lens (IOL) and other surgical instruments, is set to get a new manufacturing facility in 1,10,000 sq ft area at Veerapanchan in Tamil Nadu.
Medtronic, a leader among medical technology providers, has announced the United States Food and Drug Administration’s approval of the Medtronic Concerto/Virtuoso line of implantable cardiac devices.
Medtronic, a leader among medical technology providers, has announced the United States Food and Drug Administration’s approval of the Medtronic Concerto/Virtuoso line of implantable cardiac devices.